Neurological Biomarkers Global Market Report 2025

Global Neurological Biomarkers Market Report 2024

Neurological Biomarkers Global Market Report 2025 – By Product (Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, Other Products), By Application (Alzheimer’s Disease, Parkinson’s Disease, Huntington's Disease, Schizophrenia, Depression, Multiple Sclerosis, Spinal Muscular Atrophy), By End-User (Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

Name: Neurological Biomarkers Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Neurological Biomarkers Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Neurological Biomarkers Global Market Report 2025

Proud Members Of

Neurological Biomarkers Market Definition

A neurological biomarker is a substance that provides objective and quantifiable information about the presence, progression, or characteristics of a neurological disorder or condition. They are used in clinical practice during drug development.

The main products of neurological biomarkers are proteomics biomarkers, genomics biomarkers, metabolomics biomarkers, imaging biomarkers, and others. Proteomics biomarkers refer to types of biomarkers that have specific proteins or patterns of proteins that can be identified and monitored by analyzing the proteins in the body fluid. They are used for various applications such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, schizophrenia, depression, multiple sclerosis, and spinal muscular atrophy by hospital laboratories, clinical diagnostic centers, research organizations, and others.

Neurological Biomarkers Market Segmentation

The neurological biomarkers market covered in this report is segmented –

1) By Product: Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, Other Products

2) By Application: Alzheimer’s Disease, Parkinson’s Disease, Huntington's Disease, Schizophrenia, Depression, Multiple Sclerosis, Spinal Muscular Atrophy

3) By End-User: Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, Other End-Users

Subsegments:

1) By Proteomics Biomarker: Protein Biomarkers, Antibody Biomarkers

2) By Genomics Biomarker: DNA Biomarkers, RNA Biomarkers

3) By Metabolomics Biomarker: Metabolite Biomarkers, Lipid Biomarkers

4) By Imaging Biomarker: MRI Biomarkers, PET Scan Biomarkers

5) By Other Products: Neuroinflammatory Biomarkers, Neurotransmitter Biomarkers

Neurological Biomarkers Market Size and growth rate 2025 to 2029: Graph

Neurological Biomarkers Market Size 2025 And Growth Rate

The neurological biomarkers market size has grown rapidly in recent years. It will grow from $10.7 billion in 2024 to $11.96 billion in 2025 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to increasing prevalence of neurological disorders, aging population, drug development needs, increased funding for neurological research, personalized medicine

Neurological Biomarkers Market Growth Forecast

The neurological biomarkers market size is expected to see rapid growth in the next few years. It will grow to $19.96 billion in 2029 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to biomarkers for early detection, biosensors, wearable devices, global health initiatives, patient-centric approach. Major trends in the forecast period include technological innovation in imaging, rapid advances in omics technologies, integration of artificial intelligence (ai), real-world evidence in biomarker validation, advancements in diagnostic technologies, collaboration between industry and research institutions.

Book your 30 minutes free consultation with our research experts

Neurological Biomarkers Market Driver: Rising Prevalence Of Neurological Diseases Fuels Momentum In Neurological Biomarker Market

The increasing prevalence of neurological diseases is expected to propel the growth of the neurological biomarker market going forward. Neurological illnesses affect the brain, spinal cord, and all of the body's other nerves. Parkinson's disease is a neurodegenerative disorder affecting the neurological system and the areas of the body that are under the control of the nerves. Neurological biomarkers help provide an early diagnosis of Parkinson's disease using pathological, biochemical, and genetic testing. For instance, in December 2022, according to the Parkinson's Foundation, a US-based non-profit organization, the number of new diagnoses of Parkinson's disease reached 90,000 in 2022, up from 60,000 per year in 2021. Therefore, the increasing prevalence of neurological diseases is driving the growth of the neurological biomarker market.

Neurological Biomarkers Market Driver: Rising Prevalence Of Schizophrenia Is A Catalyst For Advancements In Neurological Biomarkers

The increasing prevalence of schizophrenia is expected to propel the growth of the neurological biomarkers market going forward. Schizophrenia is a serious mental health disorder characterized by a range of cognitive, emotional, and behavioural symptoms. Neurological biomarkers may enable the early detection of schizophrenia, provide objective measures for diagnosis, reduce the reliance on subjective clinical assessments, and treatment personalization, reduce the stigma associated with psychiatric disorders, and contribute to a deeper understanding of the neurobiological mechanisms underlying schizophrenia. For instance, in January 2022, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations responsible for international public health, approximately 24 million people, or 1 in 300 persons (0.32%), worldwide suffer from schizophrenia. Adults experience this rate at a rate of one in 222 (0.4%) (2). Therefore, the increasing prevalence of schizophrenia is driving the growth of the neurological biomarkers market.

Global Neurological Biomarkers Market Major Players

Major companies operating in the neurological biomarkers market include Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Novartis AG, Thermos Fisher Scientific Inc., AstraZeneca Plc, Abbott Laboratories, Boehringer Ingelheim International GmbH, Becton Dickinson and Company, Agilent Technologies Inc., Grifols S.A., Eisai Co. Ltd., PerkinElmer Inc., Illumina Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Mallinckrodt Plc, Qiagen N.V., Luminex Corporation, Siemens Healthineers, Olink Proteomics, Meso Scale Diagnostics, Quanterix Corp., Fujirebio, Cisbio Bioassays SAS, NeuroVision Imaging, Proteome Sciences Plc, Acumen Pharmaceuticals.

Global Neurological Biomarkers Market Trend: Strategic Collaborations Drive Innovation In Neurological Biomarkers Market

Major companies operating in the neurological biomarkers market are forming partnerships to develop new products and strengthen their positions in the market. Collaborations and partnerships in the neurological biomarkers market foster innovation, leverage complementary expertise, and accelerate the development and commercialization of advanced therapies by combining resources and capabilities. For instance, in July 2022, NeuroSense Therapeutics Ltd., an Israel-based company developing treatments for severe neurodegenerative diseases partnered with NeuraLight, an Israel-based company developing objective and sensitive biomarkers for neurological disorders. This collaboration is to identify oculometric indicators for Amyotrophic Lateral Sclerosis (ALS) through the application of AI (Artificial Intelligence) and ML (Machine Learning). The partnership, which comes after NeuraLight's $25 million Series A financing, is to enhance the discovery and application of ALS digital indicators in a parallel study. This will be the collaboration's first clinical trial. The partnership is centered on the application of oculometric digital indicators, which may allow for patient classification and boost clinical trial success rates.

Global Neurological Biomarkers Market Trend: Revolutionizing Alzheimer's Disease Diagnosis And Patient Evaluation With Biomarker Blood Test

Major companies operating in the neurological biomarkers market are developing new products such as advanced biomarker blood tests to gain a competitive edge in the market. Biomarker blood tests involve the analysis of specific molecules or indicators in the blood that provide information about a biological condition, disease, or physiological process. For instance, in July 2023, Quanterix Corporation, a US-based company that specializes in the development and commercialization of ultra-sensitive digital immunoassay platforms launched the LucentAD biomarker blood test. The LucentAD test is intended to assist medical professionals in evaluating patients who have cognitive symptoms that align with preliminary indications of alzheimer's disease. The test quantifies levels of p-Tau 181, which has been demonstrated to be a biomarker of the pathophysiology of alzheimer's disease (AD). When an adult is being tested for AD 1 and has cognitive impairment, the LucentAD test findings are meant to be utilized as a diagnostic tool. The test is not meant to be used as a stand-alone screening or diagnostic assay and it must be used in conjunction with other diagnostic tools.

Neurological Biomarkers Market Merger And Acquisition: GE HealthCare Acquired MIM Software Inc

In April 2024, GE HealthCare, a US-based medical technology company, acquired a MIM Software Inc. for an undisclosed amount. GE HealthCare aims to enhance precision care by integrating advanced imaging analytics and streamlining workflows, ultimately improving patient outcomes and clinician efficiency. This strategic move positions GE HealthCare to deliver more personalized treatment solutions across various medical specialties. MIM Software Inc., a US-based medical imaging software company, provides advanced imaging solutions that can enhance the identification and analysis of neurological biomarkers.

Regional Outlook For The Global Neurological Biomarkers Market

North America was the largest region in the neurological biomarkers market in 2024. The regions covered in the neurological biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the neurological biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Defines the Neurological Biomarkers Market?

The neurological biomarker market consists of sales of genetic testing kits, electroencephalography (EEG) devices, and biomarker assay kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Neurological Biomarkers Industry?

The neurological biomarkers research report is one of a series of new reports from The Business Research Company that provides neurological biomarkers market statistics, including the neurological biomarkers industry's global market size, regional shares, competitors with neurological biomarkers market share, detailed neurological biomarkers market segments, market trends and opportunities, and any further data you may need to thrive in the neurological biomarkers industry. This neurological biomarker market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Neurological Biomarkers Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$11.96 billion
Revenue Forecast In 2034	$19.96 billion
Growth Rate	CAGR of 13.7% from 2024 to 2033
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Product: Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, Other Products 2) By Application: Alzheimer’s Disease, Parkinson’s Disease, Huntington's Disease, Schizophrenia, Depression, Multiple Sclerosis, Spinal Muscular Atrophy 3) By End-User: Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, Other End-Users Subsegments: 1) By Proteomics Biomarker: Protein Biomarkers, Antibody Biomarkers 2) By Genomics Biomarker: DNA Biomarkers, RNA Biomarkers 3) By Metabolomics Biomarker: Metabolite Biomarkers, Lipid Biomarkers 4) By Imaging Biomarker: MRI Biomarkers, PET Scan Biomarkers 5) By Other Products: Neuroinflammatory Biomarkers, Neurotransmitter Biomarkers
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Novartis AG, Thermos Fisher Scientific Inc., AstraZeneca Plc, Abbott Laboratories, Boehringer Ingelheim International GmbH, Becton Dickinson and Company, Agilent Technologies Inc., Grifols S.A., Eisai Co. Ltd., PerkinElmer Inc., Illumina Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Mallinckrodt Plc, Qiagen N.V., Luminex Corporation, Siemens Healthineers, Olink Proteomics, Meso Scale Diagnostics, Quanterix Corp., Fujirebio, Cisbio Bioassays SAS, NeuroVision Imaging, Proteome Sciences Plc, Acumen Pharmaceuticals.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Neurological Biomarkers Market Characteristics

3. Neurological Biomarkers Market Trends And Strategies

4. Neurological Biomarkers Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Neurological Biomarkers Growth Analysis And Strategic Analysis Framework

5.1. Global Neurological Biomarkers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Neurological Biomarkers Market Growth Rate Analysis

5.4. Global Neurological Biomarkers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Neurological Biomarkers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Neurological Biomarkers Total Addressable Market (TAM)

6. Neurological Biomarkers Market Segmentation

6.1. Global Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Proteomics Biomarker

Genomics Biomarker

Metabolomics Biomarker

Imaging Biomarker

Other Products

6.2. Global Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Alzheimer’s Disease

Parkinson’s Disease

Huntington's Disease

Schizophrenia

Depression

Multiple Sclerosis

Spinal Muscular Atrophy

6.3. Global Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Laboratories

Clinical Diagnostic Centers

Research Organizations

Other End-Users

6.4. Global Neurological Biomarkers Market, Sub-Segmentation Of Proteomics Biomarker, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Protein Biomarkers

Antibody Biomarkers

6.5. Global Neurological Biomarkers Market, Sub-Segmentation Of Genomics Biomarker, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

DNA Biomarkers

RNA Biomarkers

6.6. Global Neurological Biomarkers Market, Sub-Segmentation Of Metabolomics Biomarker, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Metabolite Biomarkers

Lipid Biomarkers

6.7. Global Neurological Biomarkers Market, Sub-Segmentation Of Imaging Biomarker, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

MRI Biomarkers

PET Scan Biomarkers

6.8. Global Neurological Biomarkers Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Neuroinflammatory Biomarkers

Neurotransmitter Biomarkers

7. Neurological Biomarkers Market Regional And Country Analysis

7.1. Global Neurological Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Neurological Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Neurological Biomarkers Market

8.1. Asia-Pacific Neurological Biomarkers Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Neurological Biomarkers Market

9.1. China Neurological Biomarkers Market Overview

9.2. China Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Neurological Biomarkers Market

10.1. India Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Neurological Biomarkers Market

11.1. Japan Neurological Biomarkers Market Overview

11.2. Japan Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Neurological Biomarkers Market

12.1. Australia Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Neurological Biomarkers Market

13.1. Indonesia Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Neurological Biomarkers Market

14.1. South Korea Neurological Biomarkers Market Overview

14.2. South Korea Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Neurological Biomarkers Market

15.1. Western Europe Neurological Biomarkers Market Overview

15.2. Western Europe Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Neurological Biomarkers Market

16.1. UK Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Neurological Biomarkers Market

17.1. Germany Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Neurological Biomarkers Market

18.1. France Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Neurological Biomarkers Market

19.1. Italy Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Neurological Biomarkers Market

20.1. Spain Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Neurological Biomarkers Market

21.1. Eastern Europe Neurological Biomarkers Market Overview

21.2. Eastern Europe Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Neurological Biomarkers Market

22.1. Russia Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Neurological Biomarkers Market

23.1. North America Neurological Biomarkers Market Overview

23.2. North America Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Neurological Biomarkers Market

24.1. USA Neurological Biomarkers Market Overview

24.2. USA Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Neurological Biomarkers Market

25.1. Canada Neurological Biomarkers Market Overview

25.2. Canada Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Neurological Biomarkers Market

26.1. South America Neurological Biomarkers Market Overview

26.2. South America Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Neurological Biomarkers Market

27.1. Brazil Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Neurological Biomarkers Market

28.1. Middle East Neurological Biomarkers Market Overview

28.2. Middle East Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Neurological Biomarkers Market

29.1. Africa Neurological Biomarkers Market Overview

29.2. Africa Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Neurological Biomarkers Market Competitive Landscape And Company Profiles

30.1. Neurological Biomarkers Market Competitive Landscape

30.2. Neurological Biomarkers Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Neurological Biomarkers Market Other Major And Innovative Companies

31.1. AstraZeneca Plc

31.2. Abbott Laboratories

31.3. Boehringer Ingelheim International GmbH

31.4. Becton Dickinson and Company

31.5. Agilent Technologies Inc.

31.6. Grifols S.A.

31.7. Eisai Co. Ltd.

31.8. PerkinElmer Inc.

31.9. Illumina Inc.

31.10. Shimadzu Corporation

31.11. Waters Corporation

31.12. Bio-Rad Laboratories Inc.

31.13. Mallinckrodt Plc

31.14. Qiagen N.V.

31.15. Luminex Corporation.

32. Global Neurological Biomarkers Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neurological Biomarkers Market

34. Recent Developments In The Neurological Biomarkers Market

35. Neurological Biomarkers Market High Potential Countries, Segments and Strategies

35.1 Neurological Biomarkers Market In 2029 - Countries Offering Most New Opportunities

35.2 Neurological Biomarkers Market In 2029 - Segments Offering Most New Opportunities

35.3 Neurological Biomarkers Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Neurological Biomarkers Market, Sub-Segmentation Of Proteomics Biomarker, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Neurological Biomarkers Market, Sub-Segmentation Of Genomics Biomarker, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Neurological Biomarkers Market, Sub-Segmentation Of Metabolomics Biomarker, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Neurological Biomarkers Market, Sub-Segmentation Of Imaging Biomarker, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Neurological Biomarkers Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Neurological Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Neurological Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Pfizer Inc. Financial Performance

Table 80: F. Hoffmann-La Roche AG Financial Performance

Table 81: Merck & Co. Inc. Financial Performance

Table 82: Novartis AG Financial Performance

Table 83: Thermo Fisher Scientific Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Neurological Biomarkers Market, Sub-Segmentation Of Proteomics Biomarker, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Neurological Biomarkers Market, Sub-Segmentation Of Genomics Biomarker, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Neurological Biomarkers Market, Sub-Segmentation Of Metabolomics Biomarker, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Neurological Biomarkers Market, Sub-Segmentation Of Imaging Biomarker, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Neurological Biomarkers Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Neurological Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Neurological Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Pfizer Inc. Financial Performance

Figure 80: F. Hoffmann-La Roche AG Financial Performance

Figure 81: Merck & Co. Inc. Financial Performance

Figure 82: Novartis AG Financial Performance

Figure 83: Thermo Fisher Scientific Inc. Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

How Will The Nuclear Medicine Market Grow In 2022?

Global Healthcare Automation Market 2022 – Market Opportunities And Strategies

Global Central Lab Market 2022 – Market Opportunities And Strategies

The Business Research Company offers the medical aesthetics market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the medical tourism market research report 2022 with industry size, share, segments and market growth

Biomarkers Global Market Report 2025 – By Technology (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers), By Disease (Neurological Diseases, Cancer, Immunological Diseases, Cardiovascular Diseases, Other Diseases), By Type (Biomarker Of Exposure, Biomarker Of Diseases), By Audiences (Pharmaceutical Companies, Government And Private Research Institutes, Academic Institutes, Medical Device Manufacturing Companies), By Application (Risk Assessment, Development of Molecular Diagnostic, Disease Diagnosis, Drug Discovery And Development, Drug Formulation, Forensic Application, Other Applications (DNA Fingerprinting And Others)) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Rare Neurological Disease Treatment Global Market Report 2025 – By Drug Type (Biologics, Small Molecules), By Therapy (Cognitive Behavioral Therapy, Interpersonal Psychotherapy, Cyberknife, Other Therapies), By Mode Of Administration (Oral, Injectable, Other Modes Of Administration), By Disorders (Aicardi Syndrome, Aicardi-Goutières Syndrome, Reflex Sympathetic Dystrophy Syndrome, Battaglia-Neri Syndrome, Creutzfeldt Jakob Disease, Agnosia, Other Disorders), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies And Drug Store, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Neurology Devices Global Market Report 2025 – By Type (Cerebrospinal Fluid Management (CSF) Devices And Equipment, Interventional Neurology Devices And Equipment, Neurosurgery Devices And Equipment, Neurostimulation Device), By Type of Expenditure (Public, Private), By Product (Instruments/Equipment, Disposables), By End User (Hospitals And Clinics, Diagnostic Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2025-203

View Report

Interventional Neurology Devices And Equipment Global Market Report 2025 – By Type (Aneurysm Coiling & Embolization Devices, Cerebrospinal Fluid Management Devices, Neurothrombectomy Devices, Support Devices), Aneurysm Coiling & Embolization Devices By Type (Embolic coils, Flow diversion devices, Liquid embolic devices), Angioplasty Devices by Type (Carotid artery stents, Embolic protection systems), Support Devices By Type, Micro guide wires, Micro catheters), Neurothrombectomy Devices By Type (CLOT retrieval devices, Suction and aspiration devices, Snare), By End-User (Hospitals, Neurology clinics, Ambulatory care centers and others) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Renal Biomarkers Global Market Report 2025 – By Biomarker Type (Functional Biomarker, Up Regulated Protein, Other Biomarker Types), By Diagnostic Technique (Enzyme-Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), Liquid Chromatography Mass Spectrometry (LS-MS)), By Application (Diagnosis And Disease Progression Monitoring, Research Homecare), By End User (Hospitals, Diagnostic Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cardiac Biomarkers Testing Global Market Report 2025 – By Biomarkers Type (Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified albumin (IMA), Other Biomarkers Types), By Application (Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications), By End-User (Hospitals, Specialty Clinics) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cardiac Biomarkers Global Market Report 2025 – By Biomarkers Type (Creatine Kinase (CK-Mb), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarker Types), By Location Of Testing (Point Of Care Testing, Laboratory Testing), By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome (ACS), Atherosclerosis, Other Applications), By End User (Hospitals, Specialty Clinics) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cancer Biomarker Global Market Report 2025 – By Biomarkers Type (Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers), By Profiling Technologies (Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics, Cytogenetics), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Thyroid Cancer, Kidney Cancer, Other Cancers), By Application (Diagnostics, Research And Development, Prognostics, Risk Assessment, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Neurological Biomarkers market?

How will the Neurological Biomarkers market drivers and restraints affect the market dynamics? What forces will shape the Neurological Biomarkers industry going forward?

The Neurological Biomarkers market major growth driver - Rising Prevalence Of Neurological Diseases Fuels Momentum In Neurological Biomarker Market. For further insights on the Neurological Biomarkers market, request a sample here

What is the forecast market size or the forecast market value of the Neurological Biomarkers market?

The Neurological Biomarkers market size has grown strongly in recent years. The neurological biomarkers market size has grown rapidly in recent years. It will grow from $10.7 billion in 2024 to $11.96 billion in 2025 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to increasing prevalence of neurological disorders, aging population, drug development needs, increased funding for neurological research, personalized medicine The neurological biomarkers market size is expected to see rapid growth in the next few years. It will grow to $19.96 billion in 2029 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to biomarkers for early detection, biosensors, wearable devices, global health initiatives, patient-centric approach. Major trends in the forecast period include technological innovation in imaging, rapid advances in omics technologies, integration of artificial intelligence (ai), real-world evidence in biomarker validation, advancements in diagnostic technologies, collaboration between industry and research institutions. For further insights on the Neurological Biomarkers market, request a sample here

How is the Neurological Biomarkers market segmented?

The neurological biomarkers market covered in this report is segmented –
1) By Product: Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, Other Products
2) By Application: Alzheimer’s Disease, Parkinson’s Disease, Huntington's Disease, Schizophrenia, Depression, Multiple Sclerosis, Spinal Muscular Atrophy
3) By End-User: Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, Other End-Users Subsegments:
1) By Proteomics Biomarker: Protein Biomarkers, Antibody Biomarkers
2) By Genomics Biomarker: DNA Biomarkers, RNA Biomarkers
3) By Metabolomics Biomarker: Metabolite Biomarkers, Lipid Biomarkers
4) By Imaging Biomarker: MRI Biomarkers, PET Scan Biomarkers
5) By Other Products: Neuroinflammatory Biomarkers, Neurotransmitter Biomarkers For further insights on the Neurological Biomarkers market, request a sample here

Which region has the largest share of the Neurological Biomarkers market? What are the other regions covered in the report?

North America was the largest region in the neurological biomarkers market in 2024. The regions covered in the neurological biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the Neurological Biomarkers market, request a sample here.

Who are the major players in the Neurological Biomarkers market?

What are the key trends in the Neurological Biomarkers market?

Major trends in the Neurological Biomarkers market include Strategic Collaborations Drive Innovation In Neurological Biomarkers Market. For further insights on the Neurological Biomarkers market, request a sample here.

What are the major opportunities in the Neurological Biomarkers market? What are the strategies for the Neurological Biomarkers market?

For detailed insights on the major opportunities and strategies in the Neurological Biomarkers market, request a sample here.

How does the Neurological Biomarkers market relate to the overall economy and other similar markets?

For detailed insights on Neurological Biomarkers's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Neurological Biomarkers industry?

For detailed insights on the mergers and acquisitions in the Neurological Biomarkers industry, request a sample here.

What are the key dynamics influencing the Neurological Biomarkers market growth? SWOT analysis of the Neurological Biomarkers market.

For detailed insights on the key dynamics influencing the Neurological Biomarkers market growth and SWOT analysis of the Neurological Biomarkers industry, request a sample here.